Vir Biotechnology is a U.S.-based biotechnology company focused on discovering and developing medicines for serious infectious diseases and other conditions. Its work includes antibody, T-cell, vaccine, and small-molecule research and development.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!